231 related articles for article (PubMed ID: 33309270)
21. Testosterone treatment and change of categories of the International prostate symptom score (IPSS) in hypogonadal patients: 12 years prospective controlled registry study.
Yassin A; Kelly D; Nettleship J; Talib R; Al-Zoubi RM; Aboumarzouk OM; Albaba B
Aging Male; 2023 Dec; 26(1):2220567. PubMed ID: 37287273
[TBL] [Abstract][Full Text] [Related]
22. Testosterone Therapy Among Prostate Cancer Survivors.
Nguyen TM; Pastuszak AW
Sex Med Rev; 2016 Oct; 4(4):376-88. PubMed ID: 27474995
[TBL] [Abstract][Full Text] [Related]
23. Safety of testosterone therapy in men with prostate cancer.
Morgentaler A; Caliber M
Expert Opin Drug Saf; 2019 Nov; 18(11):1065-1076. PubMed ID: 31495240
[No Abstract] [Full Text] [Related]
24. Cardiovascular impact of testosterone therapy for hypogonadism.
Rastrelli G; Dicuio M; Reismann Y; Sforza A; Maggi M; Corona G
Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):617-625. PubMed ID: 30099911
[TBL] [Abstract][Full Text] [Related]
25. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.
Morales A
BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230
[TBL] [Abstract][Full Text] [Related]
26. [Prostate carcinoma and testosterone: risks and controversies].
Rhoden EL; Averbeck MA
Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):956-62. PubMed ID: 20126847
[TBL] [Abstract][Full Text] [Related]
27. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism.
Grabner M; Hepp Z; Raval A; Tian F; Khera M
J Sex Med; 2018 Feb; 15(2):148-158. PubMed ID: 29425664
[TBL] [Abstract][Full Text] [Related]
28. Testosterone therapy improves erectile function and libido in hypogonadal men.
Rizk PJ; Kohn TP; Pastuszak AW; Khera M
Curr Opin Urol; 2017 Nov; 27(6):511-515. PubMed ID: 28816715
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.
Corona G; Rastrelli G; Morgentaler A; Sforza A; Mannucci E; Maggi M
Eur Urol; 2017 Dec; 72(6):1000-1011. PubMed ID: 28434676
[TBL] [Abstract][Full Text] [Related]
30. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk.
Miner M; Morgentaler A; Khera M; Traish AM
Clin Endocrinol (Oxf); 2018 Jul; 89(1):3-10. PubMed ID: 29486065
[TBL] [Abstract][Full Text] [Related]
31. Risks of testosterone replacement therapy in ageing men.
Tan RS; Salazar JA
Expert Opin Drug Saf; 2004 Nov; 3(6):599-606. PubMed ID: 15500418
[TBL] [Abstract][Full Text] [Related]
32. Testosterone deficiency and cardiovascular mortality.
Morgentaler A
Asian J Androl; 2015; 17(1):26-31. PubMed ID: 25432501
[TBL] [Abstract][Full Text] [Related]
33. Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.
Traish AM
Sex Med Rev; 2018 Jan; 6(1):86-105. PubMed ID: 29128268
[TBL] [Abstract][Full Text] [Related]
34. Update on Testosterone Replacement Therapy in Hypogonadal Men.
Leung KM; Alrabeeah K; Carrier S
Curr Urol Rep; 2015 Aug; 16(8):57. PubMed ID: 26077352
[TBL] [Abstract][Full Text] [Related]
35. Androgen replacement in men undergoing treatment for prostate cancer.
Rhoden EL; Averbeck MA; Teloken PE
J Sex Med; 2008 Sep; 5(9):2202-8. PubMed ID: 18638000
[TBL] [Abstract][Full Text] [Related]
36. Guideline of guidelines: testosterone therapy for testosterone deficiency.
Salter CA; Mulhall JP
BJU Int; 2019 Nov; 124(5):722-729. PubMed ID: 31420972
[TBL] [Abstract][Full Text] [Related]
37. Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis.
Seftel AD; Kathrins M; Niederberger C
Mayo Clin Proc; 2015 Aug; 90(8):1104-15. PubMed ID: 26205546
[TBL] [Abstract][Full Text] [Related]
38. Testosterone and the prostate: implications for the treatment of hypogonadal men.
Holyoak JD; Crawford ED; Meacham RB
Curr Urol Rep; 2008 Nov; 9(6):500-5. PubMed ID: 18947516
[TBL] [Abstract][Full Text] [Related]
39. Varicocele Repair Versus Testosterone Therapy for Older Hypogonadal Men with Clinical Varicocele and Low Testosterone.
Bernie HL; Goldstein M
Eur Urol Focus; 2018 Apr; 4(3):314-316. PubMed ID: 30316825
[TBL] [Abstract][Full Text] [Related]
40. Testosterone therapy and prostate carcinoma.
Rhoden EL; Averbeck MA
Curr Urol Rep; 2009 Nov; 10(6):453-9. PubMed ID: 19863857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
